Cargando…
LMTK2 as Potential Biomarker for Stratification between Clinically Insignificant and Clinically Significant Prostate Cancer
A set of prostate tumors tend to grow slowly and do not require active treatment. Therefore, stratification between patients with clinically significant and clinically insignificant prostate cancer (PC) remains a vital issue to avoid overtreatment. Fast development of genetic technologies accelerate...
Autores principales: | Vezelis, Alvydas, Simiene, Julija, Dabkeviciene, Daiva, Kincius, Marius, Ulys, Albertas, Suziedelis, Kestutis, Jarmalaite, Sonata, Jankevicius, Feliksas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7803409/ https://www.ncbi.nlm.nih.gov/pubmed/33488712 http://dx.doi.org/10.1155/2021/8820366 |
Ejemplares similares
-
Systematic and MRI-Cognitive Targeted Transperineal Prostate Biopsy Accuracy in Detecting Clinically Significant Prostate Cancer after Previous Negative Biopsy and Persisting Suspicion of Malignancy
por: Vėželis, Alvydas, et al.
Publicado: (2021) -
Clinical Significance of ADAMTS19, BMP7, SIM1, and SFRP1 Promoter Methylation in Renal Clear Cell Carcinoma
por: Kubiliute, Raimonda, et al.
Publicado: (2021) -
Immunophenotype Rearrangement in Response to Tumor Excision May Be Related to the Risk of Biochemical Recurrence in Prostate Cancer Patients
por: Bosas, Paulius, et al.
Publicado: (2021) -
Urinary DNA as a Tool for Germline and Somatic Mutation Detection in Castration-Resistant Prostate Cancer Patients
por: Januskevicius, Tomas, et al.
Publicado: (2023) -
Evaluation of Renal Function after Partial Nephrectomy and Detection of Clinically Significant Acute Kidney Injury
por: Makevičius, Jurijus, et al.
Publicado: (2022)